Roxithromycin [80214-83-1]
R5992
Estimated Purity≥96%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameRoxithromycin [80214-83-1]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥96%
- FormatSoluble in HCl, and NaOH. Slightly soluble in alcohol and water. Soluble in chloroform (10 mg/mL).
- Scientific DescriptionMacrolide; protein synthesis inhibitor.; Rulide, Surlid, Rotramin, Claramid, Overal, Rossitrol
- Storage Instruction4°C
- UNSPSC12352200
References
- Ci X, Chu X, Xu X, et al. Short-term roxithromycin treatment attenuates airway inflammation via MAPK/NF-kappaB activation in a mouse model of allergic asthma. Inflamm Res. 2012 Jul;61(7):749-58. PMID: 22481373. Biava M, Porretta GC, Deidda D, et al. New trends in development of antimycobacterial compounds. Infect Disord Drug Targets. 2006 Jun;6(2):159-72. PMID: 16789877. Urasaki Y, Nori M, Iwata S, et al. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. J Rheumatol. 2005 Sep;32(9):1765-74. PMID: 16142877. Berman M, Hasdai D, Raanani E, et al. Ex-vivo effect of roxithromycin on human and rat arterial vasoactivity. Interact Cardiovasc Thorac Surg. 2005 Jun;4(3):232-7. PMID: 17670399.